SEC Tracker
Get the app

aTYR PHARMA ATYR

aTYR PHARMA amends ATM offering details

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Up to $79,994,251 in common stock available for sale
  2. Sales agreement with Jefferies LLC allows at-the-market offerings
  3. Previously sold 445,732 shares for $70.0 million
  4. Jefferies earns up to 3.0% commission on sales

Written from the 424B5 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when aTYR PHARMA files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Arvinas ARVN public float $469M, Jun 30, 2025
  2. Arbutus Biopharma ABUS public float $472M, Jun 30, 2025
  3. Zevra Therapeutics ZVRA public float $455M, Jun 30, 2025
  4. Theravance Biopharma TBPH public float $449M, Jun 30, 2025
  5. Myriad Genetics MYGN public float $494M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.